Bénard F, Bujold R, Nabid A
Faculté de médecine, Université de Sherbrooke, Département de médecine nucléaire et radiobiologie.
Union Med Can. 1994 Mar;123(3):163-5, 168-71.
To assess the use of complementary tests by oncologists during staging and follow-up of breast cancer patients, a study was performed comparing actual procedures with current literature recommendations. A survey concerning the use of biochemical, radiological and radionuclide tests was presented to a sample of 58 radiation oncologists and medical oncologists involved in the treatment of breast cancer patients, with a 71% response rate. During the post-treatment surveillance, respectively 3%, 24%, 37%, 76% and 96% of the physicians scheduled liver scans, liver ultrasounds, bone scans, chest roentgenograms or mammograms on a regular basis. The frequency of use of various procedures are reported with a reference to the cost-benefit ratio, a matter of current interest. Although most oncologists limit their use of diagnostic tests, some still rely on extensive work-up to detect early recurrences or metastases, an approach that remains controversial in today's literature.
为评估肿瘤学家在乳腺癌患者分期及随访过程中对补充检查的使用情况，开展了一项研究，将实际操作与当前文献建议进行比较。向参与乳腺癌患者治疗的58名放射肿瘤学家和医学肿瘤学家发放了一份关于生化、放射和放射性核素检查使用情况的调查问卷，回复率为71%。在治疗后监测期间，分别有3%、24%、37%、76%和96%的医生定期安排肝脏扫描、肝脏超声、骨扫描、胸部X光检查或乳房X光检查。报告了各种检查程序的使用频率，并参考了成本效益比，这是当前人们感兴趣的问题。尽管大多数肿瘤学家限制诊断检查的使用，但仍有一些人依赖全面检查来检测早期复发或转移，这种方法在当今文献中仍存在争议。
